Multidisciplinary

Top Medical News
Pearl Toh, 14 hours ago
Use of over-the-counter (OTC) painkillers during pregnancy is associated with an increased risk of adverse neonatal outcomes, suggests a large retrospective study presented at ESHRE 2021.
15 hours ago
Women who experience early menopause appear to be at increased risk of developing lung cancer, but this association is limited to smokers, according to the results of a meta-analysis.
17 hours ago
The incidence of in-hospital mortality is greater among patients with deep venous thrombosis (DVT) involving the inferior vena cava than those with DVT at other locations, a study has found. Additionally, pelvic vein DVT is not associated with higher mortality or more in-hospital embolism when compared with proximal lower extremity DVT.
18 hours ago
Treatment for chronic hepatitis B virus (CHB) infection results in significant reductions in risk of cirrhosis among noncirrhotic CHB patients, according to a study.
20 hours ago
Most studies and clinical trials regarding the novel coronavirus disease (COVID-19) fail to consider sex and gender as important variables affecting outcomes, a recent study has found.
21 hours ago
Older inflammatory bowel disease (IBD) patients who receive the recombinant zoster vaccine are less likely to develop herpes zoster infection, as shown in a study.
23 hours ago
Chronic lower back pain is directly associated with degree of stress, a recent Korea study has found.
Special Reports
01 Jul 2021
Psoriasis is a chronic inflammatory skin disease and can be classified as ‘mild’, ‘moderate’, or ‘severe’. The management of psoriasis should always be based on its severity and individual patient preferences – it should not be more unpleasant than the disease itself. The two most commonly prescribed classes of topical treatment for psoriasis are vitamin D analogues and topical corticosteroids. In this case study, Dr Tan Wooi Chiang shares his clinical experience treating plaque psoriasis with a combined formulation of betamethasone dipropionate and calcipotriol monohydrate in a single spray foam (Enstilar® Foam, LEO Pharma). 
01 Jul 2021
Plaque psoriasis is the most common form of psoriasis and is characterised by sharply demarcated erythematous plaques. The first-line management of this condition is with topical treatments, including vitamin D analogues and topical corticosteroids. In this case study, Dr Tan Wooi Chiang shares his clinical experience treating plaque psoriasis with a combined formulation of betamethasone dipropionate and calcipotriol monohydrate in a single spray foam (Enstilar® Foam, LEO Pharma).
01 Jul 2021
 At the recent Adult Vaccine Online Academy program webinar supported by Pfizer, Dr Petrick Periyasamy, head of the Hospital Canselor Tuanku Muhriz UKM Infectious Diseases Unit, and Dr Charles Feldman, Distinguished Professor of Pulmonology at South Africa’s University of Witwatersrand, discussed issues surrounding adult pneumococcal vaccination.
16 Jun 2021
Ceftaroline fosamil 600 mg powder for infusion
16 Jun 2021
Perindopril arginine 3.5 mg,
Amlodipine besilate 2.5 mg tab
16 Jun 2021
Furfuryl Palmitate
16 Jun 2021
Letermovir 240 mg film-coated tab and infusion conc
Conference Reports
Pearl Toh, 24 Jul 2021
Use of over-the-counter (OTC) painkillers during pregnancy is associated with an increased risk of adverse neonatal outcomes, suggests a large retrospective study presented at ESHRE 2021.
Roshini Claire Anthony, 23 Jul 2021

In patients with type 2 diabetes (T2D) with cardiovascular (CV) risk factors or impaired kidney function, weekly doses of the exendin-based GLP-1* receptor agonist (RA) efpeglenatide may reduce their risk of major adverse cardiovascular events (MACE) or kidney outcomes, according to findings from the AMPLITUDE-O trial presented at ADA 2021.

Audrey Abella, 23 Jul 2021
Findings from real-world studies presented at ECCMID 2021 showed improved survival outcomes with remdesivir in hospitalized COVID-19 patients.

Elaine Soliven, 23 Jul 2021
Treatment with casirivimab/imdevimab combination therapy appears to be associated with a reduced risk of hospitalization or death compared with bamlanivimab/etesevimab in outpatients with COVID-19 infected by the Gamma variant, according to a study presented at ECCMID 2021.
Audrey Abella, 22 Jul 2021
Phase II data presented at ADA 2021 showed the potential of the GRA* volagidemab to improve glycaemic control in patients with type 1 diabetes (T1D).
Audrey Abella, 21 Jul 2021
The monoclonal antibody regdanvimab showed promise in the treatment of patients with mild-to-moderate* COVID-19, a pivotal phase II/III trial has shown.
Elaine Soliven, 21 Jul 2021
Ertugliflozin significantly improves glycaemic outcomes in patients with type 2 diabetes (T2D) who have stage 3 chronic kidney disease (CKD), according to a subgroup analysis of the VERTIS CV* trial presented at ADA 2021.